AI English summary of an SEC filing — figures as filed
CVS Health CVSThe company said total revenues for the 3-month period Q3 2025 rose to $102,871 million, up from $95,428 million a year earlier, and that it posted an operating loss of $(3,207) million compared with operating income of $832 million in the prior-year period.
Key points
AI summaryThe company said total revenues for the 3-month period Q3 2025 rose to $102,871 million, up from $95,428 million a year earlier, and that it posted an operating loss of $(3,207) million compared with operating income of $832 million in the prior-year period.
CVS Health said it recorded a goodwill impairment charge of $5.7 billion related to the Health Care Delivery reporting unit in Q3. It said it reviewed the charge after revising its strategy to reduce the number of new primary care clinics it would open from 2026 onward.
The company said its GAAP diluted loss per share for Q3 was $3.13, compared with earnings per share of $0.07 a year earlier, and that Adjusted EPS was $1.60, versus $1.09 in the prior-year period. It cited improved adjusted operating income in the Health Care Benefits segment as the driver of the Adjusted EPS increase.
The company raised its full-year 2025 Adjusted EPS guidance to $6.55 to $6.65 from $6.30 to $6.40, and said its cash flow from operations guidance is $7.5 billion to $8.0 billion. Cash flow from operations for the 9 months ended 2025 was $7.2 billion.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
CVS Health posts Q3 2025 revenue of $102,871 million, operating loss of $(3,207) million
The company said total revenues for the 3-month period Q3 2025 rose to $102,871 million, up from $95,428 million a year earlier, and that it posted an operating loss of $(3,207) million compared with operating income of $832 million in the prior-year period.
Source · Based on the filing body and exhibits
Goodwill impairment charge of $5.7 billion tied to Health Care Delivery
CVS Health said it recorded a goodwill impairment charge of $5.7 billion related to the Health Care Delivery reporting unit in Q3. It said it reviewed the charge after revising its strategy to reduce the number of new primary care clinics it would open from 2026 onward.
Source · Based on the filing body and exhibits
Q3 GAAP diluted loss per share of $3.13, Adjusted EPS $1.60
The company said its GAAP diluted loss per share for Q3 was $3.13, compared with earnings per share of $0.07 a year earlier, and that Adjusted EPS was $1.60, versus $1.09 in the prior-year period. It cited improved adjusted operating income in the Health Care Benefits segment as the driver of the Adjusted EPS increase.
Source · Based on the filing body and exhibits
2025 full-year outlook and 9-month operating cash flow $7.2 billion
The company raised its full-year 2025 Adjusted EPS guidance to $6.55 to $6.65 from $6.30 to $6.40, and said its cash flow from operations guidance is $7.5 billion to $8.0 billion. Cash flow from operations for the 9 months ended 2025 was $7.2 billion.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…